documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

3,813 rows where agency_id = "FDA" and posted_year = 2010 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 5

posted_year 1

  • 2010 · 3,813 ✖

agency_id 1

  • FDA · 3,813 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2010-E-0662-0001 FDA FDA-2010-E-0662 Aventis Pharma S.A. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:23Z   0 0 0900006480bc2a98
FDA-2010-N-0118-0005 FDA FDA-2010-N-0118 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Imported Food under 2002 Public Health Security and Bioterrorism Preparedness and Response Act of 2002 Notice N-Notice 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2010-12-30T14:44:54Z 2010-32946 0 0 0900006480bc26ef
FDA-1997-N-0020-0047 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:38Z   0 0 0900006480bc1cde
FDA-2010-N-0356-0004 FDA FDA-2010-N-0356 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Designated New Animal Drugs for Minor Use and Minor Species Notice N-Notice 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2010-12-30T14:39:28Z 2010-32948 0 0 0900006480bc26eb
FDA-2010-E-0656-0001 FDA FDA-2010-E-0656 Amgen Inc. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-08-11T04:43:36Z   0 0 0900006480bc285b
FDA-1997-N-0020-0034 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:15Z   0 0 0900006480bc0e46
FDA-1997-N-0020-0022 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:19:54Z   0 0 0900006480bc0dca
FDA-1997-N-0020-0038 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:22Z   0 0 0900006480bc1ae6
FDA-2010-E-0656-0003 FDA FDA-2010-E-0656 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2010-12-30T16:57:57Z   0 0 0900006480bc28a7
FDA-2010-E-0659-0001 FDA FDA-2010-E-0659 Amgen Inc. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:21Z   0 0 0900006480bc28b0
FDA-1997-N-0020-0024 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:19:58Z   0 0 0900006480bc0dcc
FDA-1997-N-0020-0025 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:19:59Z   0 0 0900006480bc0dd0
FDA-1997-N-0020-0029 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:07Z   0 0 0900006480bc0e41
FDA-1997-N-0020-0035 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:17Z   0 0 0900006480bc0e47
FDA-2010-E-0662-0002 FDA FDA-2010-E-0662 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-08-11T01:39:02Z   0 0 0900006480bc2a9a
FDA-2010-E-0661-0002 FDA FDA-2010-E-0661 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:23Z   0 0 0900006480bc2a28
FDA-1997-N-0020-0023 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:19:56Z   0 0 0900006480bc0dcb
FDA-1997-N-0020-0044 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:33Z   0 0 0900006480bc1cd8
FDA-2010-E-0656-0002 FDA FDA-2010-E-0656 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:21Z   0 0 0900006480bc285c
FDA-1997-N-0020-0030 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:08Z   0 0 0900006480bc0e42
FDA-1997-N-0020-0039 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:24Z   0 0 0900006480bc1ae7
FDA-1997-N-0020-0043 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:31Z   0 0 0900006480bc1cd6
FDA-1997-N-0020-0028 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:05Z   0 0 0900006480bc0e40
FDA-1997-N-0020-0046 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:37Z   0 0 0900006480bc1cda
FDA-1997-N-0020-0049 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:42Z   0 0 0900006480bc210a
FDA-1997-N-0020-0036 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:19Z   0 0 0900006480bc0e6a
FDA-2010-E-0657-0002 FDA FDA-2010-E-0657 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2010-12-30T18:00:32Z   0 0 0900006480bc28ab
FDA-2010-E-0657-0001 FDA FDA-2010-E-0657 Amgen Inc. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-08-11T01:39:02Z   0 0 0900006480bc28a9
FDA-1997-N-0020-0048 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:40Z   0 0 0900006480bc2109
FDA-1997-N-0020-0027 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:03Z   0 0 0900006480bc0e3f
FDA-1997-N-0020-0037 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:21Z   0 0 0900006480bc0e6b
FDA-1997-N-0020-0026 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:01Z   0 0 0900006480bc0e3e
FDA-2010-E-0657-0003 FDA FDA-2010-E-0657 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2010-12-30T18:00:33Z   0 0 0900006480bc28ae
FDA-2010-E-0659-0003 FDA FDA-2010-E-0659 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:22Z   0 0 0900006480bc29ce
FDA-2010-E-0663-0002 FDA FDA-2010-E-0663 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-08-11T04:43:37Z   0 0 0900006480bc2a9e
FDA-2010-E-0663-0001 FDA FDA-2010-E-0663 Danek, et al. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:23Z   0 0 0900006480bc2a9c
FDA-1997-N-0020-0042 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:30Z   0 0 0900006480bc1b4e
FDA-1997-N-0020-0031 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:10Z   0 0 0900006480bc0e43
FDA-1997-N-0020-0032 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:12Z   0 0 0900006480bc0e44
FDA-1997-N-0020-0040 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:26Z   0 0 0900006480bc1b4a
FDA-1997-N-0020-0045 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:35Z   0 0 0900006480bc1cd9
FDA-1997-N-0020-0041 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:28Z   0 0 0900006480bc1b4d
FDA-1997-N-0020-0033 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Background Material Supporting & Related Material BKG-Background Material 2010-12-30T05:00:00Z 2010 12     2010-12-30T13:20:14Z   0 0 0900006480bc0e45
FDA-2010-E-0659-0002 FDA FDA-2010-E-0659 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:22Z   0 0 0900006480bc29cc
FDA-2010-E-0661-0001 FDA FDA-2010-E-0661 Aventis Pharma S.A. - Patent Term Extension Application Other APP-Application 2010-12-30T05:00:00Z 2010 12 2010-12-30T05:00:00Z   2013-07-27T23:41:23Z   0 0 0900006480bc2a24
FDA-2010-E-0653-0001 FDA FDA-2010-E-0653 Gilead Sciences, Inc. - Patent Term Extension Application Other APP-Application 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:14Z   0 0 0900006480bc1ee3
FDA-2008-E-0266-0008 FDA FDA-2008-E-0266 U.S. Patent and Trademark Office to Johnson & Johnson - Notice of Final Determination Letter Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:14Z   0 0 0900006480bc1ecf
FDA-1978-N-0021-0034 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Attachment 2 - FDA Alert (12/11/2008) [FDA-1978-N-0021-0032] Supporting & Related Material LET-Letter (Supporting and Related Material) 2010-12-29T05:00:00Z 2010 12     2010-12-29T19:21:54Z   0 0 0900006480bc2184
FDA-2010-E-0653-0002 FDA FDA-2010-E-0653 U.S. Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:14Z   0 0 0900006480bc1ee5
FDA-2010-N-0001-0163 FDA FDA-2010-N-0001 Meetings: Pulmonary-Allergy Drugs Advisory Committee Notice NM-Notice of Meeting 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2010-12-29T15:23:00Z 2010-32735 0 0 0900006480bc1b9a
FDA-1997-N-0020-0018 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 3 - Memorandum for the Heads of Executive Departments and Agencies, June 1, 1998, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:47:06Z   0 0 0900006480bc13ac
FDA-1978-N-0021-0035 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Attachment 3 - FDA Alert (5/2006) [FDA-1978-N-0021-0032] Supporting & Related Material BKG-Background Material 2010-12-29T05:00:00Z 2010 12     2010-12-29T19:30:50Z   0 0 0900006480bc2187
FDA-2010-E-0654-0002 FDA FDA-2010-E-0654 U.S Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:17Z   0 0 0900006480bc2342
FDA-2010-E-0655-0002 FDA FDA-2010-E-0655 U.S Patent and Trademark Office to FDA - Letter Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:17Z   0 0 0900006480bc2344
FDA-1997-N-0020-0015 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Index of Background Material re Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:42:44Z   0 0 0900006480bc0bea
FDA-1997-N-0020-0014 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 FDA/CFSAN to the Division of Dockets Management, February 6, 2006 Other Memorandum 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2011-10-26T21:51:50Z   0 0 0900006480bc0beb
FDA-1997-N-0020-0021 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 6 - Guidance for Industry: Frequently Asked Questions About GRAS, December 2004, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:48:28Z   0 0 0900006480bc13da
FDA-1978-N-0021-0033 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Attachment 1 - Letter to Peter S. Reichertz, Esq [FDA-1978-N-0021-0032] Supporting & Related Material LET-Letter (Supporting and Related Material) 2010-12-29T05:00:00Z 2010 12     2010-12-29T19:16:08Z   0 0 0900006480bc2182
FDA-1997-N-0020-0020 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 5 - Nanotechnology Task Force Report 2007, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:48:05Z   0 0 0900006480bc13d9
FDA-1997-N-0020-0016 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 1 - Experience With GRAS Notices Under the 1997 Proposed Rule, November 4, 2010, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:45:51Z   0 0 0900006480bc0bec
FDA-1978-N-0021-0032 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Letter from FDA/CDER to Peter S. Reichertz, Esq. and Christopher A. Brown, Esq. Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2016-09-13T15:18:53Z   0 0 0900006480bc2181
FDA-2010-E-0654-0001 FDA FDA-2010-E-0654 Gilead Sciences, Inc. - Patent Term Extension Application Other APP-Application 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-07-27T23:41:17Z   0 0 0900006480bc225b
FDA-2010-E-0655-0001 FDA FDA-2010-E-0655 Gilead Sciences, Inc. - Patent Term Extension Application Other APP-Application 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2013-08-11T03:12:28Z   0 0 0900006480bc2343
FDA-1978-N-0021-0036 FDA Over-the-Counter (OTC) Laxative FDA-1978-N-0021 Attachment 4 - Science Backgrounder: Safethy of Sodium Phosphates Oral Solution [FDA-1978-N-0021-0032] Supporting & Related Material LET-Letter (Supporting and Related Material) 2010-12-29T05:00:00Z 2010 12     2010-12-29T19:35:46Z   0 0 0900006480bc226a
FDA-2010-N-0640-0001 FDA FDA-2010-N-0640 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Data To Support Food and Nutrition Product Communications, as Used by Food and Drug Administration Notice N-Notice 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z 2011-03-01T04:59:59Z 2010-12-29T15:29:12Z 2010-32739 0 0 0900006480bc1bc0
FDA-1997-N-0020-0019 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 4 - Notification for New Use of a Food Contact Substance, FDA Form No. 3480, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:47:37Z   0 0 0900006480bc13ad
FDA-1997-N-0020-0017 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Reference 2 - GAO, FDA Should Strengthen Its Oversight of Food Ingredients Determinationed to Be Generally Recognized as Safe (GRAS) Report No. GAO-10-246, February 2010, Substances Generally Recognized as Safe; Reopening of the Comment Period re FDA-1997-N-0020-0013 Supporting & Related Material Reference (internal unless indicated) 2010-12-29T05:00:00Z 2010 12     2011-10-26T21:46:25Z   0 0 0900006480bc13ab
FDA-2010-N-0511-0003 FDA FDA-2010-N-0511 FDA/DDM Letter to Division of Wyeth Holdings - Letter Other LET-Letter 2010-12-29T05:00:00Z 2010 12 2010-12-29T05:00:00Z   2010-12-29T14:34:06Z   0 0 0900006480bc1b46
FDA-2010-N-0198-0003 FDA FDA-2010-N-0198 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notification Notice N-Notice 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T16:44:38Z 2010-32508 0 0 0900006480bc11ca
FDA-2010-P-0326-0003 FDA FDA-2010-P-0326 Determination that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: TRANDATE (Labetalol Hydrochloride) Tablets, 300 Milligrams and 400 Milligrams Notice N-Notice 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T16:37:57Z 2010-32507 0 0 0900006480bc11ac
FDA-2008-E-0261-0008 FDA FDA-2008-E-0261 U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination Other LET-Letter 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2013-07-27T23:40:43Z   0 0 0900006480bc0e70
FDA-2010-N-0002-0088 FDA FDA-2010-N-0002 New Animal Drugs: Deslorelin Rule NFR-Notice of Final Rule 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T15:43:43Z 2010-32554 0 0 0900006480bc0c09
FDA-2009-E-0014-0007 FDA FDA-2009-E-0014 U.S. Patent & Trademark Office to Abbott Diabetes Care Inc. - Letter with enclosure Other LET-Letter 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2013-07-27T23:40:43Z   0 0 0900006480bc0e15
FDA-2010-N-0001-0161 FDA FDA-2010-N-0001 Meetings: Anesthetic and Life Support Drugs Advisory Committee Notice NM-Notice of Meeting 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T16:11:53Z 2010-32591 0 0 0900006480bc0c47
FDA-2008-E-0258-0008 FDA FDA-2008-E-0258 U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination Other LET-Letter 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2013-07-27T23:40:43Z   0 0 0900006480bc0e6e
FDA-2008-E-0260-0008 FDA FDA-2008-E-0260 U.S. Patent and Trademark Office to Nixon Peabody LLP - Notice of Final Determination Other LET-Letter 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2013-08-11T03:12:26Z   0 0 0900006480bc0e72
FDA-2010-N-0002-0089 FDA FDA-2010-N-0002 Freedom of Information Summary - [NADA-141-319] - Deslorelin acetate Injection Horses/Estrous mares Other FOIS-Freedom of Information Summary (No Federal Register Publication) 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T16:01:31Z   0 0 0900006480bc13dc
FDA-2010-N-0001-0162 FDA FDA-2010-N-0001 Request for Nominations: Voting and Non-Voting Members of Public Advisory Committees or Panels Notice N-Notice 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2010-12-28T16:28:32Z 2010-32624 0 0 0900006480bc1153
FDA-2010-N-0447-0003 FDA FDA-2010-N-0447 Agency Information Collection Activities; Proposals, Submissions, and Approvals: Third Party Review Program Under the Food and Drug Administration Modernization Act Notice N-Notice 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z   2011-03-14T20:37:01Z 2010-32603 0 0 0900006480bc0c82
FDA-1997-N-0020-0013 FDA Substances Generally Recognized as Safe (GRAS) - Closed FDA-1997-N-0020 Substances Generally Recognized as Safe; Reopening of the Comment Proposed Rule Reopening of Comment Period 2010-12-28T05:00:00Z 2010 12 2010-12-28T05:00:00Z 2011-03-29T03:59:59Z 2016-09-29T01:00:28Z 2010-32344 0 0 0900006480bc0c0f
FDA-2010-N-0511-0002 FDA FDA-2010-N-0511 FDA/DDM Letter to Division of Wyeth Holdings - Letter Other   2010-12-28T00:00:00Z 2010 12     2010-12-29T14:18:57Z   0 1 0900006480b77e4c
FDA-2010-N-0001-0160 FDA FDA-2010-N-0001 Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting Notice NM-Notice of Meeting 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2010-12-27T14:48:01Z 2010-32367 0 0 0900006480bc03c3
FDA-2010-P-0630-0009 FDA FDA-2010-P-0630 Acknowledgement Letter to Heyltex Corporation, HEYL Chemisch-Pharmazeutische Fabrik GmbH & Co. KG - Correction Other Correction(s) 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2012-05-09T22:38:35Z   0 0 0900006480bbd326
FDA-2010-E-0037-0007 FDA FDA-2010-E-0037 U.S. Patent & Trademark Office to FDA/CDER - Letter with enclosure Other LET-Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-07-27T23:40:38Z   0 0 0900006480bc087d
FDA-2010-N-0001-0159 FDA FDA-2010-N-0001 Oncologic Drugs Advisory Committee; Cancellation Notice N-Notice 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2010-12-27T14:44:55Z 2010-32413 0 0 0900006480bc0306
FDA-2010-P-0630-0008 FDA FDA-2010-P-0630 Attachment XII - "Jekat, F. et al. IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids - Heyltex Corporation - [HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:31:41Z   0 0 0900006480bb3e08
FDA-2010-P-0628-0004 FDA FDA-2010-P-0628 Attachment I - "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:14:05Z   0 0 0900006480bb2c17
FDA-2010-P-0630-0006 FDA FDA-2010-P-0630 Attachment VI - "Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements" - Heyltex Corporation - [HEYL Chemisch-pharmazeutische Fabrik GmbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:29:18Z   0 0 0900006480bb3df7
FDA-2010-P-0628-0006 FDA FDA-2010-P-0628 Attachment V - Breustedt, B. et al, "Development of biokinetic models for the description of the effect of DTPA with regard to the diagnostic and therapy of incorporation of plutonium and other transuranium elements" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:18:35Z   0 0 0900006480bb30db
FDA-2010-P-0628-0007 FDA FDA-2010-P-0628 Attachment VII - "Mayak Worker Study Project 2.4 Volume III Internal Dosimetry Dose Reconstruction Methods Used in Preparation of Doses-2005 Database" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:19:56Z   0 0 0900006480bb30de
FDA-2009-E-0020-0009 FDA FDA-2009-E-0020 U.S. Patent & Trademark Office to Millen, White, Zelano & Branigan, P.C. - Notice of Final Determinaton Other LET-Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-08-11T03:12:25Z   0 0 0900006480bc0880
FDA-2004-E-0266-0009 FDA Patent Extension Application for Sensipar (cinacalcet hydrochloride), U.S. Patent No. 6,011,068 - CLOSED FDA-2004-E-0266 U.S. Patent & Trademark Office to Connolly Bove Lodge & Hutz LLP - Notice of Final Determinaton Other LET-Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-07-27T23:40:38Z   0 0 0900006480bc087f
FDA-2010-P-0582-0005 FDA FDA-2010-P-0582 Acknowledgement Letter to Lachman Consultant Services, Inc. Other ACK-Acknowledgement Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-07-27T23:37:21Z   0 0 0900006480b8a212
FDA-2010-P-0582-0003 FDA FDA-2010-P-0582 Attachment 2 - "Description Information, Mercaptopurine Tablets, USP" - [Lachman Consultant Services, Inc. - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T18:31:36Z   0 0 0900006480b8a0c0
FDA-2010-P-0628-0005 FDA FDA-2010-P-0628 Attachment II - "Federal Register/ Vol. 68, No. 178/ Monday, September 15, 2003/Notice" - Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:16:46Z   0 0 0900006480bb2c18
FDA-2007-E-0048-0008 FDA FDA-2007-E-0048 U.S. Patent & Trademark Office to Harness, Dickey & Pierce, PLC - Notice of Final Determinaton Other LET-Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-08-11T01:38:57Z   0 0 0900006480bc0881
FDA-2010-P-0628-0008 FDA FDA-2010-P-0628 Attachment XI - "IPCS Evaluation of Antidotes for Poisoning by Metals and Metalloids" Heyltex Corporation [Heyl Chemisch-pharmazeutische Fabrik GnbH & Co. KG - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T19:36:22Z   0 0 0900006480bb30e2
FDA-2010-P-0582-0002 FDA FDA-2010-P-0582 Attachment 1 "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations" - [Lachman Consultant Services, Inc. - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T18:31:35Z   0 0 0900006480b8a0bf
FDA-2010-P-0582-0004 FDA FDA-2010-P-0582 Attachment 3 - "Description Information, Purinethol - Mercaptopurine Tablets, Gate Pharmaceuticals" - [Lachman Consultant Services, Inc. - Citizen Petition] Supporting & Related Material CP-Citizen Petition (Supporting & Related Materials) 2010-12-27T05:00:00Z 2010 12     2010-12-27T18:31:38Z   0 0 0900006480b8a15d
FDA-2010-V-0587-0002 FDA FDA-2010-V-0587 Acknowledgement Letter to Syndicate Hospitality Group Other ACK-Acknowledgement Letter 2010-12-27T05:00:00Z 2010 12 2010-12-27T05:00:00Z   2013-07-27T23:37:31Z   0 0 0900006480b93263

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);